We are discovering and developing a variety of drug candidates to broaden the universe of patients benefiting from cancer immunotherapy.
As part of this mission we are conducting a variety of clinical trials alone and together with our collaborators. We currently conduct nine ongoing clinical trials in Europe and the US in the cancer immunotherapy field spanning several solid tumor indications.
- To see our current pipeline of investigational therapies, click here.
- For more information about our ongoing clinical trials, visit clinicaltrials.gov.
- For any further questions on our ongoing and future trials contact us at Patients@biontech.de.
- To learn more about how clinical trials work, visit the National Institutes of Health (NIH) website.